Amount Raised
$63 Million
Round Type
series c
Description
Ophthalmic diseases-driven therapy specialist Neurophth Biotechnology has raised nearly 400 million yuan ($63 million) in a Series C round of financing, per a company statement on Monday
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech